InfuSystems Holdings PE Ratio 2010-2024 | INFU
Current and historical p/e ratio for InfuSystems Holdings (INFU) from 2010 to 2024. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. InfuSystems Holdings PE ratio as of May 20, 2024 is 0.00.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| InfuSystems Holdings PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2024-05-20 | 6.49 | inf | |
| 2024-03-31 | 8.57 | 0 | 0.00 |
| 2023-12-31 | 10.54 | $0.03 | 351.33 |
| 2023-09-30 | 9.64 | $0.04 | 241.00 |
| 2023-06-30 | 9.63 | $0.03 | 321.00 |
| 2023-03-31 | 7.75 | 0 | 0.00 |
| 2022-12-31 | 8.68 | $0.00 | 0.00 |
| 2022-09-30 | 6.99 | $0.01 | 699.00 |
| 2022-06-30 | 9.63 | $-0.03 | 0.00 |
| 2022-03-31 | 9.80 | $0.02 | 490.00 |
| 2021-12-31 | 17.03 | $0.07 | 243.29 |
| 2021-09-30 | 13.03 | $0.54 | 24.13 |
| 2021-06-30 | 20.79 | $0.70 | 29.70 |
| 2021-03-31 | 20.36 | $0.85 | 23.95 |
| 2020-12-31 | 18.78 | $0.80 | 23.48 |
| 2020-09-30 | 12.82 | $0.35 | 36.63 |
| 2020-06-30 | 11.54 | $0.26 | 44.38 |
| 2020-03-31 | 8.49 | $0.09 | 94.33 |
| 2019-12-31 | 8.53 | $0.06 | 142.17 |
| 2019-09-30 | 5.29 | $0.01 | 0.00 |
| 2019-06-30 | 4.30 | $-0.07 | 0.00 |
| 2019-03-31 | 5.01 | $-0.11 | 0.00 |
| 2018-12-31 | 3.44 | $-0.05 | 0.00 |
| 2018-09-30 | 3.25 | $-0.83 | 0.00 |
| 2018-06-30 | 3.55 | $-0.81 | 0.00 |
| 2018-03-31 | 2.90 | $-0.84 | 0.00 |
| 2017-12-31 | 2.30 | $-0.92 | 0.00 |
| 2017-09-30 | 2.05 | $-0.15 | 0.00 |
| 2017-06-30 | 1.75 | $-0.14 | 0.00 |
| 2017-03-31 | 2.30 | $-0.06 | 0.00 |
| 2016-12-31 | 2.55 | $0.03 | 85.00 |
| 2016-09-30 | 2.78 | $0.14 | 19.86 |
| 2016-06-30 | 2.60 | $0.20 | 13.00 |
| 2016-03-31 | 3.52 | $0.20 | 17.60 |
| 2015-12-31 | 3.02 | $0.16 | 18.88 |
| 2015-09-30 | 2.76 | $0.12 | 23.00 |
| 2015-06-30 | 3.19 | $0.10 | 31.90 |
| 2015-03-31 | 2.71 | $0.11 | 24.64 |
| 2014-12-31 | 3.15 | $0.16 | 19.69 |
| 2014-09-30 | 3.14 | $0.15 | 20.93 |
| 2014-06-30 | 2.65 | $0.14 | 18.93 |
| 2014-03-31 | 2.78 | $0.10 | 27.76 |
| 2013-12-31 | 2.14 | $0.07 | 30.57 |
| 2013-09-30 | 1.28 | $0.04 | 32.00 |
| 2013-06-30 | 1.49 | $0.01 | 149.00 |
| 2013-03-31 | 1.74 | $-0.03 | 0.00 |
| 2012-12-31 | 1.50 | $-0.07 | 0.00 |
| 2012-09-30 | 1.76 | $-0.12 | 0.00 |
| 2012-06-30 | 1.89 | $-0.91 | 0.00 |
| 2012-03-31 | 1.94 | $-2.18 | 0.00 |
| 2011-12-31 | 1.61 | $-2.15 | 0.00 |
| 2011-09-30 | 0.95 | $-2.22 | 0.00 |
| 2011-06-30 | 2.16 | $-1.42 | 0.00 |
| 2011-03-31 | 2.70 | $-0.10 | 0.00 |
| 2010-12-31 | 2.33 | $-0.09 | 0.00 |
| 2010-09-30 | 2.50 | $0.07 | 35.71 |
| 2010-06-30 | 2.55 | $0.04 | 63.75 |
| 2010-03-31 | 2.45 | $0.18 | 13.61 |
| 2009-12-31 | 2.20 | $0.04 | 55.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.138B | $0.126B |
| InfuSystem is a rapidly growing healthcare services company that provides state-of-the-art electronic continuous ambulatory infusion pumps, supplies and support to oncology practices and clinics throughout the United States. More than 60% of oncologists across all 50 states turn to InfuSystem as their single, full-service source for cost-effective infusion pump management. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $179.548B | 23.51 |
| Stryker (SYK) | United States | $125.611B | 30.08 |
| Medtronic (MDT) | Ireland | $112.214B | 15.89 |
| Boston Scientific (BSX) | United States | $110.560B | 35.22 |
| EssilorLuxottica (ESLOY) | France | $102.987B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $43.408B | 0.00 |
| Haleon (HLN) | United Kingdom | $38.858B | 28.37 |
| ResMed (RMD) | United States | $32.134B | 30.17 |
| Terumo (TRUMY) | Japan | $26.594B | 37.56 |
| Koninklijke Philips (PHG) | Netherlands | $25.426B | 19.70 |
| Zimmer Biomet Holdings (ZBH) | United States | $24.492B | 15.64 |
| Baxter (BAX) | United States | $17.846B | 12.69 |
| Insulet (PODD) | United States | $12.897B | 57.19 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $11.375B | 0.00 |
| Demant (WILYY) | Denmark | $11.282B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $8.326B | 27.23 |
| BellRing Brands (BRBR) | United States | $7.474B | 35.15 |
| Lantheus Holdings (LNTH) | United States | $5.744B | 14.31 |
| Haemonetics (HAE) | United States | $4.838B | 23.94 |
| GN Store Nord (GNNDY) | Denmark | $4.400B | 24.71 |
| Perrigo (PRGO) | Ireland | $4.027B | 12.21 |
| Prestige Consumer Healthcare (PBH) | United States | $3.230B | 15.37 |
| Envista Holdings (NVST) | United States | $3.140B | 12.96 |
| Neogen (NEOG) | United States | $2.961B | 28.48 |
| Maravai LifeSciences Holdings (MRVI) | United States | $2.851B | 0.00 |
| QuidelOrtho (QDEL) | United States | $2.839B | 15.76 |
| Green Thumb Industries (GTBIF) | United States | $2.604B | 51.58 |
| TG Therapeutics (TGTX) | United States | $2.547B | 71.65 |
| ICU Medical (ICUI) | United States | $2.516B | 22.20 |
| Agios Pharmaceuticals (AGIO) | United States | $1.884B | 0.00 |
| LeMaitre Vascular (LMAT) | United States | $1.782B | 52.23 |
| Verano Holdings (VRNOF) | United States | $1.676B | 0.00 |
| Warby Parker (WRBY) | United States | $1.654B | 0.00 |
| InMode (INMD) | Israel | $1.596B | 8.48 |
| Owens & Minor (OMI) | United States | $1.377B | 12.00 |
| AdaptHealth (AHCO) | United States | $1.317B | 9.79 |
| National Vision Holdings (EYE) | United States | $1.221B | 38.85 |
| AtriCure (ATRC) | United States | $1.062B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.005B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.853B | 0.00 |
| Evolus (EOLS) | United States | $0.840B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.738B | 15.72 |
| Cresco Labs (CRLBF) | United States | $0.736B | 0.00 |
| Quanterix (QTRX) | United States | $0.659B | 0.00 |
| Valneva SE (VALN) | France | $0.616B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.614B | 14.43 |
| PetIQ (PETQ) | United States | $0.593B | 19.38 |
| Surmodics (SRDX) | United States | $0.500B | 31.30 |
| Jin Medical (ZJYL) | China | $0.474B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.472B | 0.00 |
| ZimVie (ZIMV) | United States | $0.465B | 39.60 |
| Aurora Cannabis (ACB) | Canada | $0.404B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.365B | 11.74 |
| Cerus (CERS) | United States | $0.361B | 0.00 |
| Biote (BTMD) | United States | $0.350B | 8.06 |
| Zynex (ZYXI) | United States | $0.336B | 45.91 |
| Sanara MedTech (SMTI) | United States | $0.281B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.276B | 27.31 |
| TriSalus Life Sciences (TLSI) | United States | $0.272B | 0.00 |
| MacroGenics (MGNX) | United States | $0.267B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.243B | 15.31 |
| Veru (VERU) | United States | $0.208B | 0.00 |
| Organigram Holdings (OGI) | Canada | $0.206B | 0.00 |
| Ayr Wellness (AYRWF) | United States | $0.201B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.200B | 0.00 |
| Omeros (OMER) | United States | $0.191B | 0.00 |
| High Tide (HITI) | Canada | $0.173B | 0.00 |
| Eagleford Energy (GRUSF) | United States | $0.169B | 81.00 |
| InterCure (INCR) | Israel | $0.154B | 26.00 |
| Quipt Home Medical (QIPT) | United States | $0.138B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.132B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.128B | 18.14 |
| Cellectar Biosciences (CLRB) | United States | $0.113B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.096B | 0.00 |
| MariMed (MRMD) | United States | $0.094B | 0.00 |
| Brainsway (BWAY) | Israel | $0.091B | 0.00 |
| Fonar (FONR) | United States | $0.091B | 7.82 |
| Chimerix (CMRX) | United States | $0.088B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.081B | 0.00 |
| Safety Shot (SHOT) | United States | $0.071B | 0.00 |
| Zevia PBC (ZVIA) | United States | $0.069B | 0.00 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.060B | 3.91 |
| Apyx Medical (APYX) | United States | $0.055B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.055B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.053B | 0.00 |
| Bright Green (BGXX) | United States | $0.043B | 0.00 |
| United-Guardian (UG) | United States | $0.042B | 15.20 |
| Modular Medical (MODD) | United States | $0.037B | 0.00 |
| ImmuCell (ICCC) | United States | $0.037B | 0.00 |
| Exagen (XGN) | United States | $0.032B | 0.00 |
| Nephros (NEPH) | United States | $0.024B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.019B | 0.00 |
| Agape ATP (ATPC) | $0.019B | 0.00 | |
| Flora Growth (FLGC) | United States | $0.016B | 0.00 |
| FSD PHARMA (HUGE) | Canada | $0.014B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.013B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.012B | 0.00 |
| GUARDION HEALTH (GHSI) | United States | $0.010B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.009B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.008B | 0.00 |
| Leafly Holdings (LFLY) | United States | $0.004B | 0.00 |
| Sharps Technology (STSS) | United States | $0.004B | 0.00 |
| Senestech (SNES) | United States | $0.004B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.002B | 0.00 |
| Lucy Scientific Discovery (LSDI) | Canada | $0.002B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.001B | 0.00 |
| Smart For Life (SMFL) | United States | $0.000B | 0.00 |
| Bruush Oral Care (BRSH) | $0.000B | 0.00 | |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |